v3.25.4
Description of Business (Details)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Mar. 03, 2026
USD ($)
May 05, 2025
USD ($)
tranche
Oct. 31, 2024
product
Apr. 30, 2024
USD ($)
shares
Mar. 31, 2024
USD ($)
$ / shares
shares
Dec. 31, 2025
USD ($)
product
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Subsidiary, Sale of Stock [Line Items]                
Loss from operations           $ 32,662 $ 34,411 $ 49,233
Net loss           51,641 50,420 61,685
Net cash used in operating activities           42,265 17,999 $ 34,008
Cash and cash equivalents           53,826 86,952  
Accumulated deficit           $ 661,040 $ 609,399  
A&R Loan Agreement | Line of Credit | Secured Debt                
Subsidiary, Sale of Stock [Line Items]                
Maximum borrowing capacity   $ 250,000            
Number of tranches | tranche   3            
Maximum borrowing capacity, additionally permitted   $ 40,000            
Basis spread on variable rate, floor   3.50%            
Basis spread on variable rate   5.00%            
A&R Loan Agreement, Tranche One | Line of Credit | Secured Debt                
Subsidiary, Sale of Stock [Line Items]                
Debt drawn   $ 150,000            
A&R Loan Agreement, Tranche Three | Line of Credit | Secured Debt                
Subsidiary, Sale of Stock [Line Items]                
Maximum borrowing capacity   50,000            
A&R Loan Agreement, Tranche Two | Line of Credit | Secured Debt                
Subsidiary, Sale of Stock [Line Items]                
Maximum borrowing capacity   $ 50,000            
The Revolving Credit Facility | Line of Credit | Revolving Credit Facility | Subsequent Event                
Subsidiary, Sale of Stock [Line Items]                
Maximum borrowing capacity $ 30,000              
Line of credit facility, accordion feature, maximum limit 10,000              
Uncommitted accordion feature, electable increment amount 5,000              
Minimum utilization threshold, amount $ 10,000              
Maturity term of debt 3 years              
Basis spread on variable rate, floor 2.00%              
Basis spread on variable rate 4.25%              
Closing fee percentage 1.00%              
Prepayment fee percentage, year one 3.00%              
Prepayment fee percentage, year two 2.00%              
Prepayment fee percentage, thereafter 0.00%              
Follow-on Offering                
Subsidiary, Sale of Stock [Line Items]                
Sale of stock, number of shares issued in transaction | shares         3,554,000      
Offering price per share (in dollar per share) | $ / shares         $ 14.07      
Aggregate net proceeds from stock offering         $ 46,794      
Over-Allotment Option                
Subsidiary, Sale of Stock [Line Items]                
Sale of stock, number of shares issued in transaction | shares       318,100 533,100      
Aggregate net proceeds from stock offering       $ 4,169        
Granted options, exercisable period         30 days      
Symatese Europe Agreement                
Subsidiary, Sale of Stock [Line Items]                
Regulatory approval, number of products | product     3     4    
Symatese U.S. Agreement                
Subsidiary, Sale of Stock [Line Items]                
Expected regulatory approval, number of products | product           2